Biotage is a Global Impact Tech Company dedicated to addressing societal challenges through innovative solutions. They provide workflow solutions and products to various industries including drug discovery and development, diagnostics, analytical testing, and water and environmental testing. Committed to sustainable science, Biotage aims to create a healthier, greener, and cleaner world known as HumanKind Unlimited.

Their extensive customer base spans pharmaceutical, biotech, diagnostic, contract research, contract manufacturing, clinical, forensic, academic laboratories, as well as organizations focused on food safety, clean water, and environmental sustainability. Headquartered in Uppsala, Sweden, Biotage operates globally with over 500 employees. In 2022, they achieved sales of 1,566 MSEK, distributing products in more than 80 countries.

Biotage's shares (BIOT) are listed in the Large Cap segment on the NASDAQ Stockholm. They adhere to the Swedish Companies Act, the Code of Corporate Governance, and relevant regulations while constantly striving to exceed industry standards